Holdings

Euclidean Capital LLC

As of Sep 30, 2026, Euclidean Capital LLC reported 10 positions worth US$324M. Largest: Vanguard FTSE All-World ex-US Index Fund, iShares MSCI India ETF and ORIC Pharmaceuticals, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Vanguard FTSE All-World ex-US Index Fund3.24MUS$269MnewSep 30, 2026
iShares MSCI India ETF370KUS$17.3MnewSep 30, 2026
ORIC Pharmaceuticals, Inc.989KUS$13.3Mno changeSep 30, 2026
Teamshares Inc.1.1MUS$7.99MnewSep 30, 2026
Foghorn Therapeutics Inc.1.57MUS$5.62Mno changeSep 30, 2026
PMV Pharmaceuticals, Inc.2.63MUS$4.39Mno changeSep 30, 2026
Surrozen, Inc.87,696US$2.82Mno changeSep 30, 2026
Alector, Inc.1.31MUS$2.42Mno changeSep 30, 2026
Tenaya Therapeutics, Inc.1.02MUS$613Kno changeSep 30, 2026
Merlin, Inc.47,610US$89,507newSep 30, 2026